Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1.11M
-
Shares change
-
-394K
-
Total reported value, excl. options
-
$5.63M
-
Value change
-
-$1.83M
-
Number of buys
-
9
-
Number of sells
-
-9
-
Price
-
$5.08
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2018
27 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2018.
XBiotech Inc. - Common Shares, no par value (XBIT) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.11M shares
of 30.8M outstanding shares and own 3.6% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (438K shares), GEODE CAPITAL MANAGEMENT, LLC (135K shares), EAM Investors, LLC (126K shares), BlackRock Inc. (88.1K shares), MILLENNIUM MANAGEMENT LLC (49K shares), DIMENSIONAL FUND ADVISORS LP (45.7K shares), NORTHERN TRUST CORP (44.5K shares), STATE STREET CORP (23.2K shares), Tudor Investment Corp Et Al (21.2K shares), and BOOTHBAY FUND MANAGEMENT, LLC (21.1K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.